The role of TNF-α and PAI-1 gene polymorphisms in familial Mediterranean fever
Munis Dundar1 , Aslihan Kiraz2 , Burhan Balta1 , Elif Funda Emirogullari1 , Gokmen Zararsiz3 , Alper Yurci4 , Duran Aslan5 , Mevlut Baskol4
12 January 2012
22 March 2012
27 June 2012
PDF (member's only)
Objectives Familial Mediterranean fever (FMF) is one of the most serious inherited inflammatory disorders among Jewish, Armenian, Turkish and Arab populations. The imbalance between pro- and anti-inflammatory cytokines may play a role in its etiology. We have investigated whether tumor necrosis factor-alpha (TNF-α) and plasminogen activator inhibitor 1 (PAI-1) gene polymorphisms are associated with FMF and evaluated the relationship between these polymorphisms and genotypic manifestation of FMF.
Methods We investigated single nucleotide polymorphisms of the TNF-α promoter at positions -308 G/A and the PAI-1 4G/5G gene polymorphism in peripheral blood leukocytes collected from 177 individuals with FMF with different genotype combinations. All of the polymorphisms of TNF-α and PAI-1 were detected by PCR and restriction fragment length polymorphism analysis.
Results There were no association between the TNF-α/308 genotypes and mutations in FMF. In contrast, the PAI-1 4G/5G gene polymorphism may have a significant effect in FMF disease.
Conclusions Screening with PAI-1 gene polymorphism tests may be beneficial for tracing future FMF patients. However, further investigations are needed to reach a conclusion on the association between PAI-1 polymorphisms and FMF.
Cytokine - Familial Mediterranean fever - PAI-1 - Polymorphism - TNF-α